Agilon Health: Maintaining Hold Amid Improved EBITDA and Persistent Financial Uncertainties
Agilon Health, Inc. (NYSE:AGL) Q1 2024 Earnings Call Transcript
Deutsche Bank Adjusts Agilon Health Price Target to $5 From $8, Maintains Hold Rating
Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating.
Agilon Health Maintains Buy Rating Amidst Positive Outlook and Cost Management Efficacy
Agilon Health (AGL) Gets a Sell From Barclays
Agilon Health Inc (AGL) Q1 2024 Earnings Call Transcript Highlights: Robust Growth Amidst ...
Agilon Health Inc (AGL) Q1 2024 Earnings: Aligns With EPS Projections Despite Revenue Surge
Agilon Health Shares Are Trading Higher Following Q1 Earnings.
Agilon Health Shares Are Trading Higher Following Q1 Earnings.
Agilon Health Sees FY24 Total Revenues $6.125B-$6.175B Vs $6.5B Est. (Prior Range $6.35B-$6.365B)
Agilon Health Sees FY24 Total Revenues $6.125B-$6.175B Vs $6.5B Est. (Prior Range $6.35B-$6.365B)
Agilon Health Q1 2024 GAAP EPS $0.01 Beats $(0.01) Estimate, Sales $1.604B Inline
Agilon Health (NYSE:AGL) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by 200 percent. The company reported quarterly sales of $1.604 billion whi
Agilon Health | 10-Q: Quarterly report
Earnings Flash (AGL) AGILON HEALTH Posts Q1 Revenue $1.60B, Vs. Street Est of $1.61B
04:01 PM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (AGL) AGILON HEALTH Posts Q1 Revenue $1.60B, vs. Street Est of $1.61B
Agilon Health 1Q Rev $1.6B >AGL
Agilon Health 1Q Rev $1.6B >AGL
Press Release: Agilon Health Reports First Quarter 2024 Results
agilon health Reports First Quarter 2024 Results Revenue increased 52% to $1.6 billion, Medicare Advantage membership increased 43% to 523,000, and total members on the agilon platform grew to 654,00
Agilon Health Reports First Quarter 2024 Results
Revenue increased 52% to $1.6 billion, Medicare Advantage membership increased 43% to 523,000, and total members on the agilon platform grew to 654,000Continued progress executing performance action p
Agilon Health Announces New Physician Partnerships for 2025
agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has formed long-term partnerships with five new physician practices across the U.S. to enable their transition to a full-risk, value-based care model.
Stifel Nicolaus Reaffirms Their Hold Rating on Agilon Health (AGL)
Agilon Health Is Maintained at Hold by Stifel
Agilon Health Is Maintained at Hold by Stifel
Stifel Maintains Hold on Agilon Health, Lowers Price Target to $7
Stifel analyst Craig Jones maintains Agilon Health with a Hold and lowers the price target from $8 to $7.
Agilon Health Initiated at Neutral by Citigroup
Agilon Health Initiated at Neutral by Citigroup
No Data